What Artificial Sweeteners Actually Do to Your Small Intestine: The Cedars-Sinai Discovery

The question of whether artificial sweeteners are bad for your gut has been debated for over a decade, and for most of that time, the discussion was incomplete. Researchers were looking at the wrong part of the intestinal tract. Almost all of the early microbiome studies focused on the colon, examining fecal samples and drawing conclusions about how sweeteners affected the large intestinal microbiome. The small intestine, which processes virtually everything you eat and drink before it reaches the colon, was largely ignored. Research from Cedars-Sinai changed that by demonstrating that non-nutritive sweeteners have measurable effects on the small bowel microbiome, a finding that reframes the entire conversation. And a 2025 systematic review added further nuance by showing that synthetic sweeteners and non-synthetic alternatives do not behave the same way. This article explains what these discoveries mean, why individual responses vary so much, and how to think about sweeteners in the context of your own gut health without falling into either the 'sweeteners are poison' or 'sweeteners are completely fine' camps.

Why the small intestine matters and why it was overlooked

The human gut is not one uniform tube. The small intestine and the colon have dramatically different microbial environments, functions, and nutrient exposures. The small intestine is where most nutrient absorption occurs, where bile acids do their work, where DAO breaks down histamine, and where the migrating motor complex sweeps the lumen between meals. Its bacterial population is smaller and different in composition from the colon, which harbors the vast majority of gut bacteria.

For decades, gut microbiome research relied heavily on fecal samples because they are easy to collect non-invasively. But fecal samples primarily reflect the colonic microbiome, not the small intestinal one. This created a massive blind spot. When researchers said 'artificial sweeteners alter the gut microbiome,' they were really saying 'artificial sweeteners alter the colonic microbiome as reflected in stool.' What was happening in the small intestine, where these compounds first encounter the microbial community, was largely unknown.

The Cedars-Sinai research addressed this blind spot directly. Using small bowel aspirates and mucosal sampling techniques, the team was able to characterize the small intestinal microbiome's response to non-nutritive sweeteners. The finding that sweeteners affect this region was significant because the small intestine is where SIBO occurs, where nutrient absorption takes place, and where many functional GI symptoms originate. If sweeteners are altering the microbial environment in this segment of the gut, the implications extend well beyond the colonic effects that had been previously documented (Pimentel et al., Cedars-Sinai Medically Associated Science and Technology, 2023).

The Weizmann Institute study: personalized responses to sweeteners

Before discussing synthetic versus non-synthetic sweetener distinctions, it is important to understand one of the most significant studies in this area. In 2022, Suez and colleagues at the Weizmann Institute of Science published a randomized controlled trial in Cell that tested four non-nutritive sweeteners (saccharin, sucralose, aspartame, and stevia) in healthy adults who did not normally consume them. Each sweetener was consumed at doses below the FDA's acceptable daily intake for two weeks.

The results were striking. All four sweeteners altered the gut microbiome composition in ways that were distinct from the control groups (glucose and no supplement). Saccharin and sucralose also significantly altered glycemic responses, and importantly, the magnitude of these effects varied substantially between individuals. When the researchers transferred stool from human participants to germ-free mice, the mice developed similar glycemic alterations, suggesting the microbiome changes were causally related to the metabolic effects (Suez et al., 2022).

The personalization aspect is perhaps the most important finding. Not everyone responded the same way. The researchers were able to identify baseline microbiome signatures that predicted who would be a 'responder' (showing significant microbiome and glycemic changes) versus a 'non-responder.' This helps explain one of the most confusing aspects of the sweetener debate: the disconnect between population-level studies showing effects and individual experiences of consuming sweeteners without apparent problems.

Synthetic versus non-synthetic: the 2025 systematic review

A 2025 systematic review compiled the evidence on microbiome effects of non-nutritive sweeteners and drew an important distinction between synthetic sweeteners (sucralose, aspartame, saccharin, acesulfame potassium) and non-synthetic or naturally derived alternatives (stevia, monk fruit extract). While both categories showed evidence of microbiome modulation, the patterns differed.

Synthetic sweeteners, particularly sucralose and saccharin, showed more consistent evidence of reducing populations of beneficial bacteria, including Bifidobacterium and Lactobacillus species, across multiple studies. Sucralose in particular has been repeatedly shown in animal studies to reduce microbial diversity, alter short-chain fatty acid production, and potentially affect gut barrier function, even at doses within the acceptable daily intake (Bian et al., 2017; Rodriguez-Palacios et al., 2018). The clinical relevance of these animal findings in humans at typical consumption levels remains debated, but the consistency of the signal is noteworthy.

Non-synthetic sweeteners showed a more mixed picture. Stevia glycosides, while altering the microbiome in the Suez et al. study, have also shown potentially beneficial prebiotic-like effects in some in vitro and animal studies, with increased production of short-chain fatty acids in certain conditions (Pliestikova et al., 2023). However, stevia products vary widely in purity and processing, and many commercial stevia products contain sugar alcohols or other additives that may independently affect the gut. Monk fruit (luo han guo) extract has fewer studies but has not shown the same patterns of microbial disruption seen with synthetic sweeteners in the limited data available.

Responders versus non-responders: the role of baseline microbiome

The concept of sweetener 'responders' and 'non-responders' is one of the most important takeaways from recent research. In the Suez et al. study, the magnitude of microbiome and glycemic changes varied dramatically between individuals. Some participants showed large shifts in microbial composition and measurable changes in blood sugar regulation. Others showed minimal changes despite consuming the same sweetener at the same dose.

The baseline microbiome composition was the strongest predictor of response. Individuals whose pre-study microbiome had certain compositional features were more likely to show significant changes. This finding aligns with a broader trend in microbiome research: the effects of dietary interventions depend on the microbial ecosystem they are entering. The same food or additive can have different effects in different people because the bacteria doing the processing are different.

From a practical standpoint, this means that population-level studies may obscure real effects by averaging responders with non-responders. A study might conclude 'artificial sweeteners have no significant effect on the microbiome' when what actually happened is that 30% of participants had large effects and 70% had none, with the average washing out the signal. This is a methodological challenge that future research needs to address through subgroup analysis and individual-level data reporting.

Sugar alcohols: a different mechanism entirely

Sugar alcohols (erythritol, xylitol, sorbitol, mannitol, maltitol) are often lumped together with non-nutritive sweeteners in public discussion, but they operate through fundamentally different mechanisms. Sugar alcohols are partially absorbed in the small intestine, with the unabsorbed portion reaching the colon where it draws water by osmosis and is fermented by colonic bacteria. This is why sugar alcohols at moderate doses cause bloating, gas, and diarrhea, particularly sorbitol and maltitol.

The GI symptoms from sugar alcohols are primarily osmotic and fermentative, not microbiome-remodeling in the way that sucralose or saccharin appears to be. The clinical distinction matters. If you get bloated from a protein bar containing 15 grams of sugar alcohols, that is a predictable osmotic and fermentative effect. If you get bloated from a single diet soda containing a small amount of sucralose, that may reflect a microbiome-mediated sensitivity that involves different mechanisms and may require a different approach to manage.

What helps with figuring out your own response

Given that individual responses to sweeteners vary substantially, the most practical approach is to gather data on your own response rather than relying on blanket advice. This requires a period of systematic observation. Tracking your sweetener intake alongside your GI symptoms over 2 to 4 weeks can reveal patterns that general recommendations cannot capture. GLP1Gut can make this process straightforward by logging what you consumed and correlating it with symptom timing and severity, allowing you to see whether specific sweeteners consistently precede symptoms.

A simple elimination approach works well. If you regularly consume artificial sweeteners and have persistent GI symptoms, try eliminating all non-nutritive sweeteners for 2 to 3 weeks while tracking symptoms. If symptoms improve, reintroduce one sweetener type at a time (sucralose, then aspartame, then stevia, and so on) to identify which, if any, are problematic for you personally. This approach is low-risk, free, and provides personalized information that no population-level study can give you.

Putting it in perspective

The Cedars-Sinai findings and the broader body of research on sweeteners and the microbiome are important because they challenge the assumption that non-nutritive sweeteners are biologically inert. They are not. They interact with the gut microbial community in measurable ways, including in the small intestine where the clinical implications may be different from colonic effects.

At the same time, the evidence does not support the conclusion that all artificial sweeteners are dangerous for everyone. The dose matters, the type of sweetener matters, and your individual microbiome matters. A person who drinks one diet soda per day and has no GI symptoms is in a very different situation from a person who consumes multiple servings of different sweeteners daily and experiences chronic bloating. Context and personal response should drive decisions, not headlines.

What we can say with reasonable confidence is that the old framing of artificial sweeteners as metabolically and microbiologically inert is outdated. They have biological effects. For some people, those effects may contribute to GI symptoms. For most people, moderate consumption is probably fine. And for everyone, paying attention to your own body's response is more useful than following categorical rules.